The International Agency of Research into Cancer (IARC) is a group of expert scientists working as part of the World Health Organisation to classify things that could potentially lead to cancer into different categories, depending on how strong the...

NICE’s decision today not to recommend sorafenib – also known as Nexavar – to the NHS for the treatment of advanced liver cancer, is deeply disappointing for a number of reasons – namely the drug’s cost; the fact that it works; the questions...

A diagnosis of cancer can be a confusing time, where a lot of new information can arrive very quickly. Patients can, of course, discuss things with their doctor whilst they’re in hospital or when they visit their GPs. But it can also be enormously...

Today we published research in the British Medical Journal that looked at sunbed use amongst teenagers in England. The research has been widely covered in the media – and our spokespeople have had a busy morning being interviewed for local and national...

After almost a year and a half of campaigning, measures to help protect children from tobacco marketing were yesterday enshrined into law. The Health Bill 2009, which bans the display of tobacco at the point of sale and prohibits tobacco vending...

Regular readers of this blog will have noticed a flurry of posts over the past month covering the 2009 NCRI Cancer Conference, which took place at the beginning of October. Such events are a fantastic opportunity to hear about the latest research and...